Transition of Notes under EMTN Programme

First Abu Dhabi Bank P.J.S.C.
08 October 2024
 

First Abu Dhabi Bank P.J.S.C. (FAB)

8 October 2024

Transition for Reference Rates for Certain Series of Notes Issued Under the Euro Medium Term Note Programme

First Abu Dhabi Bank PJSC ("FAB") would like to notify all affected noteholders that we have successfully transitioned the reference rates for the following floating-rate notes issued under the Base Prospectus dated 16 July 2019 and the Base Prospectus dated 16 July 2020 of our Euro Medium Term Note Programme from LIBOR to SOFR and Term SOFR, as applicable (the "Notes"):

US$ 50,000,000 Floating Rate Notes due 2029 (ISIN: XS2047618769)

US$ 35,000,000 Floating Rate Notes due 2025 (ISIN: XS2126204325)

US$ 20,000,000 Floating Rate Notes due 2025 (ISIN: XS2193857658)

US$ 30,000,000 Floating Rate Notes due 2025 (ISIN: XS2202830381)

US$ 95,000,000 Floating Rate Notes due 2025 (ISIN: XS2206321999)

US$ 20,000,000 Floating Rate Notes due 2025 (ISIN: XS2215046660)

US$ 20,000,000 Floating Rate Notes due 2026 (ISIN: XS2284336679)

US$ 20,000,000 Floating Rate Notes due 2026 (ISIN: XS2288097210)

US$ 300,000,000 Floating Rate Notes due 2026 (ISIN: XS2289573482)

All noteholders are advised that this transition has been completed in line with regulatory guidelines and terms of the respective Note issuance documentation. No further action is required from noteholders.

For further information regarding the updated terms and conditions of the transitioned listed Notes, including the specific SOFR and Term SOFR conventions, please refer to the Amended and Restated Final Terms or Pricing Supplements available on the FAB website at https://www.bankfab.com/en-ae/about-fab/investor-relations/debt-investor-information/final-terms.

For more information, please visit https://www.bankfab.com/or FAB Investor Relations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings